Search results
Mrs. North Texas to vie for Mrs. Texas America - Herald Democrat
The Herald Democrat· 16 hours agoThis region recently gained a new community advocate who wants to use her voice to bring a wider...
Can Dupilumab Halt Atopic March in Pediatric AD?
Medscape· 6 days agoDupilumab therapy was more effective than conventional treatments in reducing the risk of developing allergic rhinitis or asthma in children with atopic...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 6 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
Asthma Treatment During Pregnancy: Stay the Course!
Medscape· 5 days agoPregnancy is a period of asthma instability; it entails an increased risk for exacerbations. While therapeutic de-escalation, if not the outright...
Legal Cannabis Product Labeling Misses the Mark in Canada
Medscape· 4 days agoCanada's legalization of cannabis oil and other nonmedical cannabis products in 2018 has not led to...
Osteoarthritis Drugs Need Trials With Appropriate Endpoints
Medscape· 4 days agoThe hypothesis that pivotal clinical trials for osteoarthritis (OA)-modifying therapies are not...
Liver Resection Improves Survival in Early Multinodular HCC
Medscape· 4 days agoA large analysis demonstrated longer 3- and 5-year survival rates in patients with early...
Bariatric Surgery Lowers CV Risk in People With Sleep Apnea
Medscape· 3 days agoWeight loss achieved through bariatric surgery lowered the risk of major adverse cardiovascular events (MACE) by 42% and all-cause mortality by 37% in people who were obese and had moderate-to-severe ...
New Guidance on CGRPs: How/Will it Shape Clinical Practice?
Medscape· 5 days agoNew Guidance on CGRPs as First-Line Migraine Prevention: How/Will it Change Clinical Practice? A...
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 6 days agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...